Inside Class Actions

The latest developments and trends affecting class actions

Latest from Inside Class Actions - Page 4

In its recent decision in Clippinger v. State Farm, the Sixth Circuit addressed the certification of a class in a breach-of-contract dispute over insurance valuation claims, in which the defendant contended that individualized evidence would be needed to determine whether the alleged breach caused actual monetary injury to class members.  Similar class certification issues have

In a win for implied preemption, the Ninth Circuit recently affirmed dismissal of supplement marketing claims under California’s Unfair Competition Law (UCL).  The case, Bubak v. Golo, LLC, No. 24-492 (9th Cir. Oct. 9, 2025), held that the plaintiff’s UCL claim was impliedly preempted because it depended entirely on alleged violations of the federal

Courts continue to grapple with the type of “concrete harm” that is required to confer Article III standing under TransUnion LLC v. Ramirez, 594 U.S. 413 (2021), particularly in data breach and privacy class actions.  On October 14, the Fourth Circuit contributed to this debate, holding that allegations that plaintiffs’ driver’s license data had been

The SEC has long had a policy that effectively prohibited public companies from requiring arbitration of shareholder claims under the Securities Act[1] and Securities Exchange Act.[2] Last month, the SEC announced a change to that policy. In its September 17, 2025 Policy Statement, the SEC stated that, effective September 19, 2025, “the

In a recent decision by the United States District Court for the Northern District of Illinois, Judge Georgia N. Alexakis narrowed and struck class claims alleging that the University of Chicago Medical Center’s use of pixel technology violated the Electronic Communications Privacy Act (ECPA).

The plaintiff, Sophia Hartley, asserted on behalf of a putative class

A court in the Southern District of New York recently dismissed a proposed class action alleging that consumers paid a premium for juice products advertised as “made simply” with “all natural ingredients,” reasoning that the plaintiff lacked standing in light of flaws in his testing allegations.  See Lurenz v. Coca-Cola Co., 2025 WL 2773188 (S.D.N.Y.